Data through FY2026 Q3 (Jun 30, 2026)
Nurix Therapeutics, Inc.
Company profile for Nurix Therapeutics, Inc. covers 30 filings across the reporting window. FY2026 certified median offer: $150,000.
- FY2026 certified median
- $150,000
- Total filings
- 30
- FY2026 25th–75th percentile
- $129,709–$165,000
- Top job title
- Scientist I, Preclinical Pharmacology
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 9 | $137,500 | $113,750 | $153,750 |
| FY2025 | 15 | $140,000 | $115,000 | $149,750 |
| FY2026 (Q1–Q3) | 6 | $150,000 | $129,709 | $165,000 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Scientist I, Preclinical Pharmacology2 filings
- Scientist II, Cell Screening and Pharmacology2 filings
- Associate Director, Chemical Development1 filings
- Associate Director, Clinical Data Management1 filings
- Associate Director (Clinical Pharmacology)1 filings
- Associate Director, Pharmaceutical Development1 filings
- Associate Director, Pharmacovigilance QMS and Compliance1 filings
- Associate Director, Pharmacovigilance Scientist1 filings
- Data Engineer1 filings
- Medicinal Chemistry Contractor1 filings
Top cities
- San Francisco21 filings
- Brisbane5 filings
- Menlo Park1 filings
- San Francisc1 filings
- Monrovia1 filings
- The Woodlands1 filings